Tethys Bioscience's Series A Round

Tethys Bioscience raised a round of funding on October 11, 2005. Investors include Mohr Davidow Ventures.

Tethys Bioscience is engaged in efforts to create and commercialize blood tests that accurately assess imminent disease risk with an aim of helping physicians preempt the onset of chronic cardiometabo…

Articles about Tethys Bioscience's Series A Round: